March 30, 2026 – Abbott and Flatiron Well being, a well being know-how firm advancing point-of-care options in oncology, introduced the mixing of Abbott’s intensive Precision Oncology portfolio into OncoEMR^®Flatiron’s cloud-based digital medical document (EMR) platform.

By this integration, oncology suppliers can now digitally order Abbott assessments – individually or together – and obtain standing updates and outcomes immediately inside their current OncoEMR medical workflow. Accessible Abbott assessments embody the Oncotype DX Breast Recurrence Rating®, OncoExTra®, Oncodetect® and Riskguard® assessments, giving physicians entry to the great portfolio by a single, unified expertise. This method helps extra knowledgeable remedy choices at a number of phases of most cancers care, whereas lowering administrative burdens and sustaining the give attention to affected person care.

The mixing expands entry to Abbott’s Precision Oncology assessments throughout Flatiron’s nationwide community of greater than 1,600 group most cancers care facilities, the place 4,700 suppliers present care and the place most most cancers care happens within the US.

Proceed studying